{"name":"Prove pharm","slug":"prove-pharm","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Indigotindisulfonate sodium 0.8%","genericName":"Indigotindisulfonate sodium 0.8%","slug":"indigotindisulfonate-sodium-0-8","indication":"Diagnostic visualization of ureteral function and urine flow during cystoscopy","status":"marketed"}]}],"pipeline":[{"name":"Indigotindisulfonate sodium 0.8%","genericName":"Indigotindisulfonate sodium 0.8%","slug":"indigotindisulfonate-sodium-0-8","phase":"marketed","mechanism":"Indigotindisulfonate sodium is a vital dye that is used diagnostically to visualize the urinary tract and bladder during cystoscopy and other urological procedures.","indications":["Diagnostic visualization of ureteral function and urine flow during cystoscopy","Assessment of upper urinary tract patency and obstruction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5JWW0ybHFnQndBSGFmaGM1SUlIMlEzYkM3Q00tSWtqSE50cVdjd2VMSlN5Q0RJdWlxYWpFZVBWRGxHcFlxeW1fN0Nid3JfSVpwZ2ZoSXNzMHItYU1NeXfSAWNBVV95cUxONmZ2c2F5bDB2VkJ3SmVNQTcxNTJiVk9kYUdFNThFajdNSzFPUG1SdWtvN0JVazhQUXJsVHNtajA2aFF0dm1VNEJ0d0VYZ2M2QlZHcldZV2p0RGRIQUtxSlFXSmc?oc=5","date":"2026-03-21","type":"earnings","source":"Bitget","summary":"Apellis Pharmaceuticals: Market Discounts Pipeline Risk Despite $689M Revenue Proof of Execution - Bitget","headline":"Apellis Pharmaceuticals: Market Discounts Pipeline Risk Despite $689M Revenue Proof of Execution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQdVhvZlNXRDlVSVQtNzY1LVVDOWRvNmg4cktKY1FpUlhjZTMwT2lNSk1IWnpaTU1pcWxnd2VqcEk0U21LQjJNQzNlVFZnemFnMjgydkR5dEE5R0NqbG8wUWFvSUk2M2hoNTlzclNJUUcwNWNoTmowamRFTTdEeFc0bUppeXJNdG8?oc=5","date":"2026-03-18","type":"pipeline","source":"Phys.org","summary":"White-rot fungi show promise for reducing pharmaceutical residues in biosolids - Phys.org","headline":"White-rot fungi show promise for reducing pharmaceutical residues in biosolids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZldhUFU3VkNObnA3c043WkdwMVhncWVJVVdvRHdMaTJscDYtY3IxcDkxeUJ4NVdra3pUc1lSSjBrWFF6QkM5UW5CTDRCQWVBRnF2Y2tkNktVY3k3c1lMMUJKbXlFRUM1bG1FOHdGbWxYSVpvRW5HdjJCU050cU9ObDNoMHN4MjVQT25xcUxnWHRYM1AxNjZEY1d0Z05qRTdCclowdGRHMk1aOGRHQ3g0b3lkaw?oc=5","date":"2026-03-06","type":"pipeline","source":"Fortune","summary":"Gen Z graduates who majored in ‘AI-proof’ careers like pharmacy, biology, and education are making less than $50,000 after graduation - Fortune","headline":"Gen Z graduates who majored in ‘AI-proof’ careers like pharmacy, biology, and education are making less than $50,000 aft","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOVGppMkZ4dHhJdFgycy1tQTBhZjZvNkt0ZW13WWEtdWZiSjY4anpVZTNpTk1PVW1vMUk2djk5ZEZEYWJkYngxVnhMcURrSEpodlk0QUpYUXhmUF9rS1VvX2JVUmpxNGM4cmY3bFRlemtGUDMxNmJHY2hlVzdHcDJMR1BMX0RIenJkQlBJdkhpay0?oc=5","date":"2026-01-26","type":"deal","source":"Yahoo Finance","summary":"Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026? - Yahoo Finance","headline":"Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOeld4M2QwN013U1FJT3JTZU1lc2hzX0paWXYyOGVnQk90VEMwVVBFZERFU3YxSmtiMnU5bzA0c3VvdlJCcGdubTBPeWpTSVV2ZWI2UDJaTEZESkR3WkFqN3A5QUw5VkdwTGJWVGFSZkE1ZFFmYWZDYWNrRXk3NVdJbk9LaXBpY2N4WlNDbVdLZlpjWmJhaXhZeEg4VU9vdWMxRkNqUFRKZWJER25RWjNrVldJb2p2Y25Oc2c?oc=5","date":"2026-01-26","type":"deal","source":"Barchart.com","summary":"Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026? - Barchart.com","headline":"Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPZTVnMk5xQ2tOcjNDT0k2Y0ZKMzR5V29Tdzg5TjFWd0VFN2ZNRjRPR1RaMkNEVWtUT2xXSGRBc2t2VDI0SlNJUjFYUWVId2VFM2ZTVmxzeVdzU3JvZFpFUmhWSDI2QnRZVW1NUDlwR25manhBTjlYVE9fc0RHVy16b2RoVkZWZ1JQNEZEcE1obkNpMmlBc1MtQnU5M1F4QQ?oc=5","date":"2026-01-20","type":"pipeline","source":"drugtopics.com","summary":"Q&A: New Medicare Drug Prices Proving Detrimental to Pharmacy Cashflow - drugtopics.com","headline":"Q&A: New Medicare Drug Prices Proving Detrimental to Pharmacy Cashflow","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-12-23","type":"pipeline","source":"simplywall.st","summary":"Will Weakness in GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Stock Prove Temporary Given Strong Fundamentals? - simplywall.st","headline":"Will Weakness in GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Stock Prove Temporary Given Strong Fundamentals?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNMDY2Q1BoTUFscFdQYXJqZTVzb2k2aTFzTG1nMllhTjFCMjNaRnA5MXJSYWlVeHdfcmVsTmRxQUN1a052UG5LOEY3bGVlZkZ6TWFCS1h3QnAxYV9XczR3OEVsbXRtSUxKZGdDUzk2SURsVG5kTVczX2lCeGtxSUpYajVhZGdlUUFEMXN4T013ZWJRRkM4VTR6TFd0ZEJ6VERvSDZhMVcwREpvc2JmOFBJT2x2RDd2LTZrX3llYUstOHlOYUlfZ3QyU0EzaVhvMlVKTFdfUDdydW9sQQ?oc=5","date":"2025-12-10","type":"pipeline","source":"The Quantum Insider","summary":"Qubit Pharmaceuticals and Sorbonne University Show Quantum Computers Can Outperform Classical Limits - The Quantum Insider","headline":"Qubit Pharmaceuticals and Sorbonne University Show Quantum Computers Can Outperform Classical Limits","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQSmpoQzI3TmRYY01FR0FUWUtwelVpRTA0b0RsY2dXSENaTjYwcHZuVF91QTQtdEdSQi14bDNza09iZ3FhSDc4ZW94RzF4THN5T1RWYmxja3prZGZTYmtLd05wX0RIMFFzRGM2b1BOb1NSTHMyVXNEaDIwT3NpTDVPLUlyRUdIejJrTXlXZ2hmb1VmdkZZUnozTlp5V0xhYTJmaTNWRG5mekpkajhxelVocEJfcW5SRlRQeUVkbWJXSFp1b3V0enNtWEotZlg?oc=5","date":"2025-12-02","type":"pipeline","source":"The Oklahoman","summary":"As other states ban pharmacy benefit managers, OK should show more caution | Opinion - The Oklahoman","headline":"As other states ban pharmacy benefit managers, OK should show more caution | Opinion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOcWREWm5ROTkwd01xNzR0TGp4VS1ZSThzZkFIVm4yaTc4QkVNOVBWYWQ3Tmw2M0R0S3hGVndDSzdCRlhOWDFVUE9qTmNEYlJTbnViUzBMVVg3Szl3U2QxQVRDRFlJOW04Tjc2dnlQWjF1OFdSODBZVlI4TFVLQ3o0S2FaRlJldEFfMUZtc3k2ZDliRDR6UmFma2tsMkZZU0pMYXhUUnRxMUJmSk9MWjV5QVU2dEw5UzBxQkQtMElSWVdPVmhUWjhzUFF3?oc=5","date":"2025-11-27","type":"pipeline","source":"The Pharmaceutical Journal","summary":"Minimum wage increase ‘may prove unmanageable for some pharmacy owners’, leaders warn - The Pharmaceutical Journal","headline":"Minimum wage increase ‘may prove unmanageable for some pharmacy owners’, leaders warn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOak0zX2xwakFIazJIekRtd1Z3a20xckg2ZjNhUjBLSnlFY0xHbkZITWtnUlNIa0QyQW5iS044X21qaUM3aWVzajRnQ1RFdzNoQnR2N0U4Qm80Wk9oWEsxZ0YtYWpIRHN3SXFUUU16N0tyaVNHYmZCWUZuQ0NZUXhfMFJJQkhQQmNOSk1RdUc5VUFNcEVXSHVhWElCR3NaTHRtNFo1VnFRTXJWYkx2VDRxdGxTRnlBQQ?oc=5","date":"2025-10-23","type":"pipeline","source":"Seeking Alpha","summary":"Recursion Pharmaceuticals: Premium Valuation Without Proof (Rating Downgrade) (NASDAQ:RXRX) - Seeking Alpha","headline":"Recursion Pharmaceuticals: Premium Valuation Without Proof (Rating Downgrade) (NASDAQ:RXRX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPUVNabzVORXJzd0NIMTE3TXZrcFpCQW84bTFSVzJtZExEUDJ5NEpPM2pZRkZsSktPM2QweXpqc0pCaHhIV3FwbUx5Q1hwVWxoM29CdGdsSlZCWkRwY0tSbXdQckN0U2EwLXlodXZLY0hTbTNSUHJ5bXprQk9lUkZRVEdLNHpJVnpfUzZiUEIyVmg3el9PZ0tFMUhLNU5Qdmw2ZXFiZUxRVlVOU2NiR3hLYg?oc=5","date":"2025-10-17","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Cold Chain Technologies, Teva, and Kuehne+Nagel Proves Sea Freight Viable for High-Value Pharma Shipments - Pharmaceutical Commerce","headline":"Cold Chain Technologies, Teva, and Kuehne+Nagel Proves Sea Freight Viable for High-Value Pharma Shipments","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}